3 Hours for Stroke Transfer; Astronauts’ Cardio Results; Retinal Lesions and Afib

Stroke patients are being kept at the initial transferring hospital for almost 3 hours before they go back out the door, according to U.S. registry data. (JAMA)

Cerebellar deep brain stimulation showed promise as a way to rehabilitate stroke survivors with upper limb motor impairments. (Nature Medicine)

Meanwhile, low-frequency repetitive transcranial magnetic stimulation did not appear to add to the clinical benefits of intensive training in stroke rehabilitation. (Stroke)

Yet more trouble for the Cardiosave Rescue and Hybrid intra-aortic balloons, this time a class I recall for unexpected shutdowns, the FDA announced.

The survival benefits with implantable cardioverter-defibrillator (ICD) primary prevention therapy in heart failure with reduced ejection fraction may hinge on the patient not being frail. (JACC: Heart Failure)

Could a smaller subcutaneous ICD be possible with the addition of a second shock coil? (HeartRhythm)

For survivors of cardiac arrest of presumed coronary cause and without ST-segment elevation, immediate coronary angiography did not lead to better 1-year outcomes compared with delayed angiography in the TOMAHAWK trial. (JAMA Cardiology)

The racial gap in cardiovascular disease death may be explained by social determinants of health. (Annals of Internal Medicine)

After 5 months in space, astronauts showed adequate maintenance of cardiac function with their exercise routines on the International Space Station. (Journal of the American College of Cardiology)

New risk scores predicted ischemic and bleeding events following acute coronary syndrome for the purpose of tailoring beyond the first month of dual antiplatelet therapy. (Heart)

Cardiovascular symptoms emerged in the long COVID journey of a firefighter and paramedic. (AP)

Higher triglyceride metabolism was linked to higher all-cause mortality, separate from the contributions of high plasma triglycerides and body mass index. (European Heart Journal)

What’s the daily step count necessary for a survival benefit? A meta-analysis came up with an estimate of nearly 4,000 steps a day, or just 2,337 for reduced cardiovascular mortality. (European Journal of Preventive Cardiology)

Boston Scientific announced that the FDA approved its POLARx cryoablation system for the treatment of paroxysmal atrial fibrillation (Afib).

Retinal ischemic perivascular lesions were tied to Afib in a case-control study. (Journal of the American Heart Association)

In left atrial appendage occlusion, deeper device implants portended a greater risk of device-related thrombus. (JACC: Cardiovascular Interventions)

Please enable JavaScript to view the

comments powered by Disqus.